Is ESPR stock a Buy, Sell, or Hold?

Based on our analysis, ESPR is currently a HOLD with low confidence. 📊 HOLD: ESPR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of ESPR stock?

Our analysis estimates the fair value range for ESPR to be between $2.53 and $3.11. The current price is $2.61.

What is the analyst price target for ESPR?

The average Wall Street analyst price target for ESPR is $6.99. This implies a potential upside of 167.9% from current levels.

ESPR Stock Analysis: Buy, Sell, or Hold?

ESPR - Esperion Therapeutics, Inc.

PHARMACEUTICAL PREPARATIONS

$2.61

0.00 (0.00%) ▲

5d: -8.42%

30d: -10.31%

90d: -29.46%

HOLD

LOW Confidence

Protect Your ESPR Gains

Analysis Updated: Apr 2, 2026 12:00 AM ET

Earnings: May 05, 2026 30d

Smart Money Accumulation

ESPR is down 4.6% this week, but smart money is accumulating calls. Top strike: $3.5 2026-06-18 with 7,480 OI. Call ratio: 100% View Scanner →

Strength: 7.3/10

Get Alerted When ESPR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: ESPR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 25.0%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$14.28

Based on 14.5% avg growth

INTRINSIC VALUE TODAY

$8.87

70.6% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: ESPR is currently trading at $2.61, which is considered slightly low relative to its 30-day fair value range of $2.53 to $3.11. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.9) compared to its historical average (62.1). Remarkably, the market is currently pricing in an annual earnings decline of 47.7% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, ESPR is in a strong uptrend. Immediate support is located at $2.47, while resistance sits at $2.91.

Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.99 (+167.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY LOW

Fair Price Range $2.53 - $3.11

Company Quality Score 50/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 79.5%

Protect Your Profits

Holding ESPR? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
NEUTRAL: Mixed technical signals (45/100)
BULLISH: High volume confirmation
BULLISH: Trading 167.9% below Wall St target ($6.99)
CAUTION: Recommendation downgraded due to -8.4% 5-day decline

Fair Price Analysis

30-Day Fair Range $2.53 - $3.11

Current vs Fair Value SLIGHTLY LOW

Support & Resistance Levels

Support Level $2.47

Resistance Level $2.91

Current Trend Strong Uptrend

Technical data as of Apr 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) 8.90

Wall Street Target $6.99 (+167.9%)

Revenue Growth (YoY) 143.7%

Profit Margin -5.6%

Valuation Discount vs History -47.7% cheaper

PE vs Historical 8.9 vs 62.1 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -47.7% (market-implied from PE analysis)

1-Year Target $2.35 (-10%)

2-Year Target $2.11 (-19%)

3-Year Target $1.90 (-27%)

3-Yr Target (if PE normalizes) (PE: 9→62) $13.28 (+409%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.6, Growth: 2105.3%) $20.36 (+680%)

Base: (SPY PE: 8.9, Growth: 2105.3%) $8.81 (+238%)

Bear: (PE: 7.6, Growth: 2105.3%) $7.49 (+187%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 8.9 to 62.1

Stabilization Target: $18.21 (+597.9%)

PE Expansion Potential: +597.9%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: April 04, 2026 4:50 AM ET
Data refreshes hourly during market hours. Next update: 5:50 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is ESPR showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Benjamin Halladay SELL 6424 shares 2026-03-17

Benjamin Looker SELL 5708 shares 2026-03-17

Benjamin Looker SELL 1689 shares 2026-01-20

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for ESPR.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
NBIX Neurocrine Biosciences I…	STRONG BUY 25 analysts	$178	63 BUY
ZTS Zoetis Inc	STRONG BUY 19 analysts	$151	63 BUY
LNTH Lantheus Holdings Inc	STRONG BUY 13 analysts	$91	61 BUY
BCRX BioCryst Pharmaceuticals…	STRONG BUY 12 analysts	$21	55 HOLD
HCM HUTCHMED DRC	STRONG BUY 14 analysts	$21	56 HOLD

NBIX Neurocrine Biosci…

63 BUY

ZTS Zoetis Inc

63 BUY

LNTH Lantheus Holdings…

61 BUY

BCRX BioCryst Pharmace…

55 HOLD

HCM HUTCHMED DRC

56 HOLD

Advanced ESPR Option Strategies

Professional options setups generated by AI based on today's ESPR price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ESPR

ESPR Technical Chart ESPR Price Prediction ESPR Earnings Date ESPR Investment Advisor ESPR Fair Price Analyzer ESPR Options Advisor ESPR Options Chain ESPR Options Analysis ESPR Competitors

Compare ESPR with Other Stocks

Create New Comparison

Tradestie